BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Press Releases

News for BIO-Europe® 2014 will be available soon

BIO-Europe 2013 press releases

November 14, 2013BIO-Europe® 2013 breaks all previous records for attendance and partnering The 19th annual BIO-Europe® international partnering conference (November 4–6) wrapped up last week in Vienna, Austria. The conference, organized by EBD Group in collaboration with the Biotechnology Industry Organization (BIO) and local host Life Science Austria Vienna (LISAvienna), featured nearly 18,000 one-to-one partnering meetings, an all-time record. Over 3,200 del...  more ►

October 7, 2013Tony Coles, Former Onyx Pharmaceuticals Chairman and CEO, to give keynote at BIO-Europe® 2013 in Vienna November 4–6 Tony Coles, MD, Former Chairman and CEO of Onyx Pharmaceuticals, Inc., will give the opening keynote at the 19th annual BIO-Europe® international partnering conference in Vienna, Austria, November 4–6, 2013. Coles' presentation, "The Onyx Story: Creating a Leading Oncology Company," is expected to be a big draw at the event just as Amgen and Onyx Pharmaceuticals close th...  more ►

September 11, 2013Get the most out of your partnering meetings at BIO-EuropeRead these Partnering Tips from big pharma on how to have an effective partnering meeting.
TIP 1 "We don't expect the work you do to be perfect or fully comprehensive to gain our interest, however make sure whatever you do is of high quality." – Rob Wills, VP, Alliance Management, Janssen Pharmaceuticals. TIP 2 "Know your competitors and be ready to pitch your competitive advantage all the time." – Thomas Hanke, Director, Biopharmaceuticals Innovation Sourcing...  more ►

September 5, 2013BIO-Europe® 2013 program is packed with well-known dealmakersExecutives from pharma and biotech to attend Vienna partnering event
November 4–6

Pharmaceutical executives and leaders in biotech are on board to speak at the 19th annual BIO-Europe® international partnering conference in Vienna, Austria, November 4–6, 2013. Organized by EBD Group in collaboration with the Biotechnology Industry Organization and local host Life Science Austria Vienna (LISAvienna), the event is Europe's largest partnering conference servi...  more ►

June 27, 2013Life science dealmaking is the main focus at BIO-Europe® 2013 to be held in Vienna November 4–6 The 19th annual BIO-Europe® international partnering conference will be held in Vienna, Austria, November 4–6, 2013 at the Messe Wien Exhibition and Congress Center. The fall event is organized by EBD Group in collaboration with local host Life Science Austria Vienna (LISAvienna), the life science cluster of the Republic of Austria and the City of Vienna. "Vienna's life ...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

24 March 2014 China partnering grows The Year of the Horse recently began in China, symbolizing dramatic actions, a desire for success and a desire for freedom. Those desires are evidenced in the nation’s choice of reformers as leaders, and in its continued commitment to build an invigorating life sciences community. Last year, 2013, was the prelude. As Greg Scott, President, ChinaBio®, pointed out,“We saw a doubling of partnering deals in 2013, measured by value. The USD 560 million raised through 100 deals in 2012 climbed to USD 1.2 billion and 135 deals in 2013.” That may be just the tip of the proverbial iceberg, as values aren’t announced for every deal. more ►

24 March 2014 BioBay fosters innovation for itself and others Synergy is a theme within BioBay life sciences park. BioBay includes multiple life science disciplines and is designed to promote the natural cross-fertilization of ideas through conversations over coffee as well as through structured meetings and conferences and other interactions. more ►

24 March 2014 Qiming Ventures focuses on China Qiming Ventures is one of the largest and most active healthcare investors in China. Focusing exclusively on China since its founding in 2006, Qiming has invested in more than 90 companies, including 30 life sciences companies developing pharmaceuticals, tools or medical devices. more ►

16 March 2014 Getting to “yes” with effective due diligence There is a soft side of partnering where opportunities are discovered through networking, handshakes and trading information. Eventually there comes the hard part, due diligence where potential partners assess and validate claims and representations. At BIO-Europe Spring® in Turin, a panel of business development executives hardened by negotiations shared their experiences for ensuring a successful due diligence process. more ►

13 March 2014 Big biotechs seek growth in innovative deals with small biotechs "When I look at large pharma, I see zero creativity in the way they go about a deal," said John McDonald of Biogen on the opening plenary panel at BIO-Europe Spring® 2014 in Turin, Italy. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe EBD Group BIO BIO-Europe